CBDY - Target Group Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0120
-0.0057 (-32.20%)
At close: 12:08PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0177
Open0.0150
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0080 - 0.0150
52 Week Range0.0060 - 0.1199
Volume135,501
Avg. Volume118,913
Market Cap6.722M
Beta (5Y Monthly)-1.97
PE Ratio (TTM)N/A
EPS (TTM)-0.0120
Earnings DateAug 13, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Canary RX Inc. Signs Definitive Agreement with Thrive Cannabis on New Joint Venture Cultivation Opportunity
    PR Newswire

    Canary RX Inc. Signs Definitive Agreement with Thrive Cannabis on New Joint Venture Cultivation Opportunity

    TARGET GROUP INC. (OTCQB: CBDY) ("Target" or the "Company"), is pleased to announce that its wholly owned subsidiary, Canary RX Inc. ("Canary RX") has entered into an agreement to form a Joint Venture Partnership ("JV") with THRIVE CANNABIS INC. ("Thrive") in Norfolk County, ON for the production of premium craft cannabis.

  • Canary RX Inc., Awarded 3 Licenses from Health Canada to Cultivate, Process and Sell Cannabis Pursuant to the Cannabis Act
    CNW Group

    Canary RX Inc., Awarded 3 Licenses from Health Canada to Cultivate, Process and Sell Cannabis Pursuant to the Cannabis Act

    NORFOLK COUNTY , ON, Oct. 8, 2019 /CNW/ - Target Group Inc (OTCQB: CBDY) ("Target" or the "Company"), is pleased to announce that its wholly-owned subsidiary, Canary RX Inc ("Canary"), has been granted licenses to cultivate, process and sell cannabis pursuant to the Cannabis Act (Bill C-45). Strategically located just outside of Toronto, ON , Canary RX will begin cultivating cannabis in its 44,000 square foot facility, producing 3600 kilograms annually.

  • Benzinga

    CannaKorp Brings Wisp System To Arizona, Partners With Nabis Holdings

    Target Group Inc (OTC: CBDY) and its subsidiary CannaKorp Inc. announced Thursday an agreement to distribute its Wisp Vaporizer and Wisp Pods in Arizona. The company also partnered with Nabis Holdings Inc. for the manufacturing and distribution of Wisp Pods and the sales of Wisp Vaporizers. "This strategic alliance brings an exciting new approach to the state, not only selling ultra-premium product through Wisp Pods at their soon-to-launch retail stores, but also providing a statewide, wholesale distribution network for the Wisp System," CannaKorp CEO Saul Niddam said in a statement.

  • CannaKorp Launches Pod-Based, Herbal Vaporizer System in Arizona
    CNW Group

    CannaKorp Launches Pod-Based, Herbal Vaporizer System in Arizona

    STONEHAM, MA , Sept. 19, 2019 /CNW/ - Target Group Inc. ("Target Group" or the "Company") (OTCQB: CBDY) and its subsidiary, CannaKorp ™  Inc., the developers of the world's first pod-based, herbal vaporizer system, delivering unprecedented quality, convenience and consistency, announced today that it has entered into a definitive agreement for the distribution of its Wisp Vaporizer and Wisp Pods in Arizona. CannaKorp's newly launched Wisp system is the world's first single-use pod, herbal vaporizer system, a home appliance that ensures the finest experience in converting natural botanical and beneficial herbal products into a vapor form, free of combustion, additives and without denaturing.

  • Target Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™
    CNW Group

    Target Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™

    Target Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™